Plastic surgery in the United States is entering a different phase in 2026. Demand remains high, but the dramatic post-pandemic surge has settled into a market where patients increasingly want smaller changes, shorter recoveries and results that are difficult to identify as cosmetic work.
The latest complete national procedural data from the American Society of Plastic Surgeons covers 2024. ASPS recorded nearly 1.6 million cosmetic surgical procedures, more than 28.5 million minimally invasive procedures and more than 1 million reconstructive procedures that year.
Those figures provide the clearest statistical baseline for understanding what Americans are choosing in 2026. More recent reporting from plastic surgeons points to several additional developments, including greater demand for post-GLP-1 body contouring, smaller breast implants, earlier facial procedures, fat transfer and subtle facial rejuvenation.
The largest change is not that Americans have stopped getting cosmetic work. It is that many patients now want results that preserve their existing appearance rather than substantially change it.
Here Are the Biggest Plastic Surgery Trends
| Category | Latest national figure | What is shaping demand in 2026 |
|---|---|---|
| Cosmetic surgery | Nearly 1.6 million procedures | Liposuction, breast surgery, tummy tucks and facial rejuvenation remain major procedures |
| Minimally invasive procedures | More than 28.5 million | Botox-type injections, fillers, resurfacing and skin treatments dominate |
| Reconstructive procedures | More than 1 million | Tumor removal, hand surgery and breast reconstruction account for much of the volume |
| GLP-1 patients in aesthetic practices | More than 800,000 in 2024 | Major weight loss is increasing interest in skin removal, lifts and body contouring |
| Most common cosmetic surgery | 349,728 liposuction procedures | Body contouring remains central even as preferences become more natural |
| Most common minimally invasive treatment | 9,883,711 neuromodulator injections | Botox and similar products remain far more common than surgery |
Measured procedural figures in this article refer to the latest ASPS national report rather than estimated 2026 totals. Current trends refer to what ASPS surgeons are reporting during 2026.
Liposuction Remains the Most Popular Cosmetic Surgery in the U.S.
View this post on Instagram
Liposuction remains at the top of American cosmetic surgery.
ASPS recorded 349,728 liposuction procedures in 2024, slightly above the 347,782 procedures recorded a year earlier. That followed a 7% increase between 2022 and 2023.
Breast augmentation remained second with 306,196 procedures, followed by tummy tucks, breast lifts and eyelid surgery.
| Most popular cosmetic surgeries | 2024 procedures |
|---|---|
| Liposuction | 349,728 |
| Breast augmentation | 306,196 |
| Tummy tuck | 171,064 |
| Breast lift | 153,616 |
| Eyelid surgery | 120,755 |
The ranking has become remarkably stable. Liposuction, breast augmentation, tummy tucks and breast lifts also occupied the top positions in 2023.
One reason liposuction remains popular is that its purpose differs from medical weight loss. Liposuction removes localized fat deposits and changes body contour. It is not designed as a treatment for obesity or as a substitute for substantial weight loss.
Liposuction led the list of cosmetic surgical procedures with a 23% increase since 2019, indicating its sustained popularity according to Allure. While liposuction is not primarily a weight-loss procedure, patients often wonder about its potential for weight loss according to virginiasurgicalarts.com.
By 2023, cosmetic surgery volume was up another 5%, followed by much slower growth in 2024. ASPS reported a 1% year-over-year increase in cosmetic surgery during 2024, suggesting that demand has stabilized at a high level rather than continuing to rise at the pace seen immediately after the pandemic.
Botox and Other Minimally Invasive Procedures Are Much More Common Than Surgery
The largest numbers in American aesthetics do not come from operating rooms.
More than 28.5 million cosmetic minimally invasive procedures were recorded by ASPS in 2024.
Neuromodulator injections, which include products such as Botox, Dysport, Xeomin, Jeuveau and Daxxify, accounted for nearly 9.9 million procedures.
| Most popular minimally invasive procedures | 2024 procedures |
|---|---|
| Neuromodulator injections | 9,883,711 |
| Hyaluronic acid fillers | 5,331,426 |
| Skin resurfacing | 3,703,305 |
| Laser, IPL and related skin treatments | 3,112,056 |
| Injectable lip augmentation | 1,449,565 |
Neuromodulator injections increased from about 9.48 million in 2023 to 9.88 million in 2024. Hyaluronic acid fillers increased more modestly from about 5.29 million to 5.33 million.
Convenience helps explain the difference in scale. Injectable and skin treatments generally require much less recovery than surgery and cost considerably less per treatment.
At the same time, 2026 is bringing a more selective attitude toward fillers. Some surgeons report patients moving away from repeated high-volume filler treatments and toward smaller amounts, fat transfer or surgery when structural correction is the actual goal.
Plastic Surgery Trends in 2026 Are Moving Toward Less Obvious Results
The defining aesthetic trend in 2026 is subtlety.
In its review of plastic surgery trends for 2026, ASPS surgeons described growing demand for procedures that preserve facial identity and body proportions.
Patients are asking for changes that look believable rather than dramatic.
That is affecting several areas of practice:
- Smaller and more proportionate breast implants
- Earlier facial surgery with smaller changes
- Facial fat transfer instead of relying exclusively on filler
- More conservative rhinoplasty
- Subtle eyelid and neck procedures
- Body contouring designed around natural proportions
- Revision of older cosmetic work that no longer fits the patient’s preferences
The same shift was already visible in the 2024 statistics. ASPS noted that women receiving breast augmentation were increasingly choosing smaller implants, while interest in lifts and contouring continued.
GLP-1 Weight Loss Is Now Changing Plastic Surgery
Ozempic, Wegovy, Zepbound and other GLP-1 medications have introduced a new group of patients into plastic surgery practices.
For the first time, ASPS measured weight-loss medication use among aesthetic patients in its 2024 report. More than 800,000 patients treated by participating plastic surgeons were using weight-loss medications.
Among GLP-1 patients under the care of ASPS member surgeons:
- 20% had already undergone plastic surgery
- 39% were considering a surgical procedure
- 41% were considering a nonsurgical procedure
The connection is straightforward. Major weight loss can leave loose skin and reduced volume even after a patient reaches a healthier or stable body weight.
That has created greater interest in tummy tucks, breast lifts, upper arm lifts, thigh lifts, lower body lifts and facial procedures.
NCHStats has documented how widespread GLP-1 treatment has become. Our analysis found that millions of American women are now using GLP-1 medications for diabetes, obesity and related metabolic conditions.
The scale of use makes post-weight-loss plastic surgery more than a celebrity trend. It is becoming a measurable part of the cosmetic surgery market.
Tummy Tucks, Arm Lifts and Thigh Lifts Are Part of the Post-Weight-Loss Market
Tummy tucks remained the third most common cosmetic surgery in the latest statistics, reaching 171,064 procedures in 2024.
Several less common lifting procedures also continued to grow. ASPS reported increases of about 3% for buttock and thigh lifts, 2% for upper arm lifts and 2% for neck lifts in 2024.
Those increases are significant in the context of 2026 because plastic surgeons expect post-GLP-1 patients to continue driving interest in skin removal and contouring.
Weight-loss medication cannot contract every area of stretched skin. Surgery is therefore being used after weight stabilization for patients whose main concern is excess skin rather than remaining body fat.
Breast Surgery Is Becoming More Focused on Proportion
View this post on Instagram
Breast augmentation remains one of America’s most common cosmetic operations, with 306,196 procedures recorded in 2024.
Growth, however, has slowed significantly. The procedure increased by less than 1% from 2023.
The more interesting change concerns what patients are requesting.
ASPS surgeons describe continued demand for smaller implants, fat transfer and results that match an athletic or proportionate body shape. Breast lifts also remain popular, reaching 153,616 procedures in 2024.
Breast implant removal reached 41,271 procedures.
Revision surgery is also becoming part of the 2026 conversation. Patients who received implants years ago may now want a smaller size, different shape, implant removal or another procedure that better suits their current body and preferences.
ASPS described this broader movement toward refining previous cosmetic work in August 2026. Revision is increasingly being approached as adjustment rather than simply correction of a failed procedure.
Face and Neck Surgery Is Moving Earlier
Facial surgery has also changed.
Facelift volume reached 79,058 procedures in 2024. Eyelid surgery remained much more common at 120,755 procedures, and 22,445 neck lifts were recorded.
ASPS surgeons expect facial surgery in 2026 to include more patients seeking smaller interventions before advanced signs of aging appear.
That does not mean facelifts are suddenly becoming a standard procedure for people in their 20s or 30s. It refers to a broader preference for correcting a specific problem earlier rather than waiting for a much larger operation later.
Eyelid surgery, neck work, brow procedures and limited facial rejuvenation fit particularly well with that approach.
People Ages 40 to 54 Account for a Large Share of Cosmetic Treatment
The ASPS age data show how heavily cosmetic treatment is concentrated in middle age.
People ages 40 to 54 accounted for 572,819 cosmetic surgical procedures in 2024, or about 36% of the total.
They represented:
- 45% of liposuction procedures
- 49% of tummy tucks
- 43% of breast lifts
- 42% of breast implant removals
- 51% of thigh lifts
- 52% of lower body lifts
The difference becomes even larger with injectables.
Adults ages 40 to 54 received about 5.62 million neuromodulator injections, representing 57% of all such procedures recorded by ASPS. They also accounted for half of hyaluronic acid filler procedures.
That helps explain why the current market increasingly combines surgery with smaller maintenance treatments rather than treating the two as completely separate choices.
Men Are Taking a Larger Role in Cosmetic Surgery
View this post on Instagram
Cosmetic procedures remain far more common among women, but male demand is increasingly visible.
ASPS reported in 2023 that total cosmetic procedures among men had risen 6% from the previous year, with particularly large increases in body and face procedures.
By 2026, surgeons are describing a broader acceptance of male cosmetic treatment.
According to an August 2026 ASPS review of facial plastic surgery among men, growing interest includes eyelid surgery, facelifts and neck procedures designed to preserve masculine facial characteristics.
Male patients are also seeking liposuction, gynecomastia surgery, jawline work and nonsurgical treatments.
The desired outcome follows the wider 2026 trend. Many patients want to look rested or more defined without making the procedure itself obvious.
Reconstructive Surgery Remains a Major Part of Plastic Surgery
Plastic surgery statistics include far more than elective cosmetic procedures.
More than 1 million reconstructive procedures were recorded in 2024, an increase of approximately 2% from 2023.
| Most common reconstructive procedures | 2024 procedures |
|---|---|
| Tumor removal, including skin cancer | 361,798 |
| Hand surgery | 208,480 |
| Breast reconstruction | 162,579 |
| Maxillofacial surgery | 54,747 |
| Scar revision | 54,280 |
Breast reconstruction increased from 157,740 procedures in 2023 to 162,579 in 2024.
That does not mean the percentage of mastectomy patients choosing immediate reconstruction is continuing to rise indefinitely. A separate national analysis reported by ASPS found that the immediate breast reconstruction rate had begun to stabilize after substantial long-term growth.
Breast cancer treatment itself has also improved over several decades. We also reported that U.S. breast cancer mortality has fallen substantially, even as disparities and access to treatment remain important concerns.
Social Media Still Shapes What Patients Ask For
Instagram, TikTok and other visual platforms remain influential, but their role is changing.
Social media helped normalize fillers, lip augmentation, buccal fat removal and dramatic body procedures during the previous decade. It now spreads another aesthetic ideal: cosmetic work that looks as though nothing was done.
ASPS has repeatedly warned that social media popularity is not evidence that a procedure is appropriate or safe for a particular patient.
That warning matters even more as before-and-after content is increasingly mixed with filters, edited images, paid promotions and AI-generated material.
A viral procedure can make a particular facial feature fashionable for a few years, but surgery produces changes that can last far longer than the trend that inspired it.
Some Previously Popular Looks Are Losing Ground
The move toward subtle results is also producing a retreat from several exaggerated aesthetics.
ASPS surgeons discussing procedures losing popularity in 2026 describe less enthusiasm for overly filled faces and other dramatic treatments associated with earlier cosmetic trends.
Large-volume filler is one example. Patients who repeatedly added facial filler over several years are increasingly asking about dissolving it, reducing volume or using surgical and fat-transfer approaches instead.
Breast preferences show a similar change, with smaller implants receiving more attention than the dramatically augmented appearance popular in earlier periods.
Large Brazilian butt lift results have also become less central to the current aesthetic ideal as patients move toward more proportionate body shapes.
Also, we can all see the negative effects plastic surgeries among celebrities.
Fat Transfer Is Becoming More Important in Facial and Body Procedures
Fat transfer is appearing more frequently in the 2026 discussion because it can serve two purposes at once.
Fat removed from another area of the patient’s body can be prepared and transferred to restore volume in the face or breasts.
For post-weight-loss patients, that can help address areas where body volume has fallen along with overall weight.
Facial fat grafting reached 34,260 procedures in the 2024 ASPS statistics.
Surgeons are also discussing smaller-volume techniques as part of facial rejuvenation, particularly when patients want to restore lost volume without repeatedly adding synthetic filler.
Results depend on technique, anatomy and how much transferred fat survives, so fat grafting should not be described as a guaranteed permanent substitute for filler.
Regenerative Aesthetics Is Getting Attention, but Patients Need to Separate Proven Treatments From Marketing
Regenerative treatments are another prominent theme in 2026.
ASPS surgeons have discussed platelet-rich plasma, platelet-rich fibrin, fat-derived treatments, biostimulatory products and other approaches intended to improve skin quality rather than simply add volume.
The term “regenerative” covers very different products, however, and regulatory status matters.
Exosome products are one example. The U.S. Food and Drug Administration has stated that there are no FDA-approved exosome products. Products marketed for human treatment may be subject to drug and biologic regulation.
Patients should therefore distinguish between a trend being discussed in aesthetic medicine and a product having established FDA approval for the way it is being marketed.
How Much Does Plastic Surgery Cost in 2026?
There is no single national 2026 price for cosmetic surgery.
The newest ASPS fee data provide projected ranges based on surgeon and physician fees reported for 2024. Those figures are much more useful than the older single averages because prices vary considerably by geography, surgeon and procedure complexity.
| Procedure | Latest ASPS surgeon fee range |
|---|---|
| Liposuction | $4,300 to $7,500 |
| Breast augmentation with implants | $4,575 to $8,000 |
| Breast augmentation with fat grafting | $5,500 to $9,500 |
| Breast lift | $6,500 to $11,000 |
| Breast reduction | $7,000 to $12,500 |
| Tummy tuck | $8,000 to $13,500 |
| Upper eyelid surgery | $3,000 to $5,500 |
| Lower eyelid surgery | $3,709 to $6,500 |
| Facelift | $12,000 to $19,000 |
| Neck lift | $7,500 to $13,000 |
| Rhinoplasty | $7,500 to $12,500 |
| Facial fat grafting | $3,000 to $5,500 |
| Upper arm lift | $6,000 to $10,500 |
| Lower body lift | $10,000 to $16,500 |
The ASPS fee report specifically describes these numbers as surgeon or physician fees.
The final amount paid by a patient can be higher because anesthesia, operating-room charges, medical tests, implants, prescription medicines, compression garments and other expenses can be billed separately.
Minimally Invasive Treatment Costs Also Vary Widely
Minimally invasive treatments usually cost less per visit than surgery, although repeated sessions can substantially increase long-term spending.
Botox and similar injections are commonly priced according to the amount of product used. Fillers vary by product and number of syringes, while laser and resurfacing costs depend heavily on treatment area and technology.
The lower upfront cost helps explain why injections and skin procedures produce volumes measured in millions rather than hundreds of thousands.
Regional Differences Remain Large
Plastic surgery is not distributed evenly across the United States.
ASPS reported approximately 437,800 cosmetic surgical procedures in the South Atlantic region in 2024, representing 28% of the national total.
The South Atlantic accounted for 35% of liposuction procedures and half of Brazilian butt lifts in the ASPS regional distribution.
The North Central region accounted for about 224,900 cosmetic procedures, or 14% of the national total, while the South Central region recorded about 288,600.
Regional differences reflect population size, local preferences, surgeon availability and the concentration of major aesthetic surgery markets.
The 2026 Plastic Surgery Market Looks Different From the Post-Pandemic Boom
The statistics since 2022 show two separate phases.
First came rapid post-pandemic growth. Cosmetic surgery rose 19% from 2019 to 2022. It then grew another 5% in 2023.
Growth slowed sharply in 2024, when cosmetic surgery increased approximately 1% and minimally invasive treatments rose about 1.5%.
The slower growth does not mean Americans have lost interest in plastic surgery. Procedure volumes remain extremely high.
Instead, the market appears to have moved from a rebound period into a more stable phase.
Within that stable market, patient preferences continue to move. GLP-1 use is creating demand for post-weight-loss contouring. Smaller breast implants and revision procedures fit the preference for proportion. Facial surgery is becoming less dramatic. Men represent a more visible share of aesthetic patients. Injectables remain enormous, but some patients are reassessing years of filler use.
The current GLP-1 era adds another reason for body contouring demand. We also reported on the mechanisms associated with GLP-1-style appetite and metabolic effects, although prescription GLP-1 medicines and lifestyle approaches should not be treated as interchangeable.
What the Latest Numbers Say About Plastic Surgery in America
Plastic surgery in 2026 is not being defined by one new operation.
Liposuction remains the country’s leading cosmetic surgery. Breast augmentation remains close behind. Botox-type injections dominate nonsurgical aesthetics by a huge margin, and reconstructive surgery continues to account for more than 1 million procedures.
The bigger changes are happening in patient preferences.
Many patients want smaller breast implants, less obvious facial work and cosmetic procedures that preserve their existing features. Rapid weight loss from GLP-1 medications is creating a new population seeking body and facial contouring. Men are becoming more visible in cosmetic practices. Older filler and implant work is increasingly being revised rather than simply repeated.
Measured national data also show that the market is no longer rising at the extraordinary rate seen immediately after the pandemic. Growth slowed considerably in 2024.
That makes 2026 less a story of explosive expansion and more a story of what Americans are choosing now that cosmetic treatment has become a routine part of healthcare and personal spending for a large group of patients.
Methodology
- National procedure counts: The latest complete national figures come from the 2024 American Society of Plastic Surgeons Procedural Statistics Report.
- 2026 trends: Current trends are based on ASPS reporting and interviews with member surgeons published during 2026. They are not presented as national 2026 procedure totals.
- Costs: Fee ranges use the latest ASPS surgeon and physician fee estimates. Hospital, facility, anesthesia and other charges can increase final patient costs.
- Reconstructive surgery: Cosmetic and reconstructive procedures are presented separately because reconstructive surgery includes medically necessary care following cancer, injury, congenital conditions and functional problems.
References
- American Society of Plastic Surgeons, Looking Into the Future: Plastic Surgery Trends for 2026
- American Society of Plastic Surgeons, Beyond the Facelift: How Facial Plastic Surgery Is Changing for Men
- American Society of Plastic Surgeons, The Age of Revision: Refining Rather Than Replacing
- American Society of Plastic Surgeons, Procedures Plastic Surgeons Are Doing Less of and Why
- U.S. Food and Drug Administration, FDA Information on Regenerative Medicine and Exosome Products
